Prostate Cancer
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI.
November 16, 2023
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial.
November 16, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
November 16, 2023
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas.
November 15, 2023
Disease mapping: Geographic differences in population rates of interventional treatment for prostate cancer in Australia.
November 15, 2023
Association between prediagnostic PSA and prostate cancer probability in Black and non-Hispanic White men.
November 15, 2023
National long-term survival estimates after radical prostatectomy for prostate cancer.
November 14, 2023
Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression.
November 14, 2023
Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation.
November 14, 2023
Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factors.
November 14, 2023
Social Media Interventions for Patients and Public: Opportunities and Challenges for the Urology Community
November 13, 2023